Biomea stock crashed Friday after the Food and Drug Administration placed two of the company’s diabetes treatment studies on hold, citing concerns of liver toxicity.
Biomea Stock Plummets After FDA Puts Diabetes Treatment Studies On Hold
Tag: Biomea
Biomea stock crashed Friday after the Food and Drug Administration placed two of the company’s diabetes treatment studies on hold, citing concerns of liver toxicity.